P3 Health Partners Inc. (PIII)
NASDAQ: PIII · IEX Real-Time Price · USD
0.539
+0.027 (5.36%)
At close: Jul 12, 2024, 4:00 PM
0.550
+0.011 (2.06%)
After-hours: Jul 12, 2024, 7:40 PM EDT

Company Description

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States.

It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

P3 Health Partners Inc.
P3 Health Partners logo
Country United States
Founded 2015
Industry Medical Care Facilities
Sector Healthcare
Employees 400
CEO Dr. Aric Coffman M.D.

Contact Details

Address:
2045 W Grand Ave Ste B, Pmb # 82152
Chicago, Illinois 60612-1577
United States
Phone 312-822-8897
Website p3hp.org

Stock Details

Ticker Symbol PIII
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001832511
CUSIP Number 744413105
ISIN Number US7444131053
Employer ID 85-2992794
SIC Code 8000

Key Executives

Name Position
Dr. Sherif Abdou F.A.C.E.P., FACP, M.D. Co-Founder, Chief Executive Officer and Director
Dr. Amir Bacchus M.B.A., M.D. Co-Founder, Chief Medical Officer and Director
Atul Kavthekar Chief Financial Officer and Chief Accounting Officer
William Bettermann Executive Vice President and Chief Operating Officer
Devery Goodey Senior Vice President of Technology
Roy Youngblood Director of Compliance
Leslie Fisher Senior Vice President of Legal Affairs and General Counsel
Kassi Belz APR Executive Vice President of Communications, Culture and Engagement
Todd Lefkowitz MHA Chief Managed Care Officer
Sarah Bussmann B.S.N., CRNI, M.H.A., R.N. Chief of Staff

Latest SEC Filings

Date Type Title
Jun 28, 2024 424B3 Prospectus
Jun 27, 2024 EFFECT Notice of Effectiveness
Jun 26, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Jun 18, 2024 S-3 Registration statement under Securities Act of 1933
Jun 7, 2024 8-K Current Report
May 24, 2024 8-K Current Report
May 23, 2024 8-K Current Report
May 20, 2024 8-K Current Report
May 9, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
May 9, 2024 8-K Current Report